The Florida Pediatric NCORP renewal application for grant# UG1CA189973 to continue participation in the NCI Community Oncology Research Program.
佛罗里达儿科 NCORP 续展拨款申请
基本信息
- 批准号:10468645
- 负责人:
- 金额:$ 62.37万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-08-01 至 2025-07-31
- 项目状态:未结题
- 来源:
- 关键词:African AmericanApplications GrantsBlack AmericanCancer BurdenCancer ControlCaringChildChildhoodClinical TrialsCommunitiesCommunity Clinical Oncology ProgramCommunity HospitalsCountryCountyDevelopmentDiagnosisEnrollmentEnsureFamilyFloridaGeneral HospitalsGeographyGoalsGrantHealthHispanicHomeHospitalsInterventionLatinoMainstreamingMalignant NeoplasmsMinorityOperative Surgical ProceduresPathologyPatientsPatterns of CarePediatric HospitalsPediatric OncologyPediatric Oncology GroupPopulationProceduresProtocol ComplianceProtocols documentationQuality ControlQuality of CareRadiation therapyResearchRisk FactorsScienceSiteTimeTreatment Protocolsbasecancer carecare deliverychemotherapydata qualitymemberpatient populationpopulation basedprogramsresearch based treatmentsuccess
项目摘要
Project Summary
The Florida Pediatric NCORP will be a consortium of five Florida hospitals. The NCORP will
geographically cover a large portion of Florida and will provide pediatric oncology care to the
largest population centers in Florida, the third largest state in the country. The hospitals are
located in Ft. Myers, Hollywood, Orlando, and two sites inTampa, as well as the Central Office.
Over a 34 year period the Florida Pediatric CCOP and now Florida Pediatric NCORP is among
the single largest contributor of patients to COG treatment, cancer control, and over the last two
years, cancer care delivery studies. The CCOP and now the NCORP has consistently had
outstanding compliance scores and contributes to the administration and science of COG
through its members who chair or co-chair research base protocols. The goal of the Florida
Pediatric NCORP will be a continuing effort to make available the latest advances in cancer
care to patients in Florida through participation in clinical trials and to register the majority of
their eligible patients on COG protocols, thereby providing quality care in patients’ home
communities. The Florida Pediatric NCORP will provide a unique opportunity to study a
geographically-defined population to investigate risk factors, patterns of care, and population-
based interventions. The Florida Pediatric NCORP will also maintain a Patient Log which affords
the opportunity to ensure the majority of eligible patients are registered on appropriate COG
protocols. Over the last grant cycle, the five Florida Pediatric NCORP participating sites have
averaged 270 patient registration on COG treament, cancer control, and cancer care delivery
protocols, as well as 321 biospeciem. The Florida Pediatric NCORP anticipates increased
patient registrations as more COG treatment, cancer control, and cancer care delivery protocols
become available. COG quality-control procedures will apply uniformly to the Florida Pediatric
NCORP, ensuring compliance with protocols and external review of pathology, radiotherapy,
surgery, and chemotherapy.
项目摘要
佛罗里达儿科NCORP将是一个由五家佛罗里达医院组成的财团。NCORP将
在地理上覆盖了佛罗里达的大部分地区,并将提供儿科肿瘤护理,
最大的人口中心在佛罗里达,第三大国家在该国。医院里
位于FT。迈尔斯,好莱坞,奥兰多,和两个网站在坦帕,以及中央办公室。
在34年的时间里,佛罗里达儿科CCOP和现在的佛罗里达儿科NCORP是
是COG治疗、癌症控制和过去两年中最大的患者贡献者,
多年来,癌症护理提供研究。CCOP和现在的NCORP一直都有
优秀的合规分数,并有助于COG的管理和科学
通过其主持或共同主持研究基础协议的成员。佛罗里达号的目标
儿科NCORP将继续努力,使癌症的最新进展
通过参与临床试验,为佛罗里达的患者提供护理,并登记大多数
符合COG协议的患者,从而在患者家中提供优质护理
社区.佛罗里达儿科NCORP将提供一个独特的机会,研究
地理上定义的人群,以调查风险因素、护理模式和人群-
基于干预。佛罗里达儿科NCORP还将维护患者日志,
有机会确保大多数合格患者在适当的COG上注册
协议.在上一个资助周期中,五个佛罗里达儿科NCORP参与站点
平均有270名患者登记接受COG治疗、癌症控制和癌症护理
协议以及321个生物标本。佛罗里达儿科NCORP预计会增加
患者登记作为更多COG治疗、癌症控制和癌症护理提供方案
变得可用。COG质量控制程序将统一适用于佛罗里达儿科
NCORP,确保符合方案和病理学、放射治疗的外部审查,
手术和化疗
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JEFFREY P KRISCHER其他文献
JEFFREY P KRISCHER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JEFFREY P KRISCHER', 18)}}的其他基金
Limited Competition: Continued Follow-up of Subjects and Initiation of a Second Case-control Cohort in The Environmental Determinants of Diabetes in The Young Study (TEDDY)
有限的竞争:在年轻研究中糖尿病的环境决定因素(TEDDY)中继续对受试者进行随访并启动第二个病例对照队列
- 批准号:
10398923 - 财政年份:2021
- 资助金额:
$ 62.37万 - 项目类别:
Human gene transfer & macrophage cell transplantation therapy of hereditary PAP (hPAP)
人类基因转移
- 批准号:
10403442 - 财政年份:2021
- 资助金额:
$ 62.37万 - 项目类别:
Human gene transfer & macrophage cell transplantation therapy of hereditary PAP (hPAP)
人类基因转移
- 批准号:
10179934 - 财政年份:2021
- 资助金额:
$ 62.37万 - 项目类别:
Limited Competition: Continued Follow-up of Subjects and Initiation of a Second Case-control Cohort in The Environmental Determinants of Diabetes in The Young Study (TEDDY)
有限的竞争:在年轻研究中糖尿病的环境决定因素(TEDDY)中继续对受试者进行随访并启动第二个病例对照队列
- 批准号:
10227415 - 财政年份:2021
- 资助金额:
$ 62.37万 - 项目类别:
Human gene transfer & macrophage cell transplantation therapy of hereditary PAP (hPAP)
人类基因转移
- 批准号:
10702185 - 财政年份:2021
- 资助金额:
$ 62.37万 - 项目类别:
Follow-up on Subjects, Integrative Data Analysis and Measurement of Viral Antibodies in The Environmental Determinants of Diabetes in The Young Study (TEDDY)
青年糖尿病环境决定因素研究(TEDDY)中的受试者跟踪、综合数据分析和病毒抗体测量
- 批准号:
10392400 - 财政年份:2020
- 资助金额:
$ 62.37万 - 项目类别:
Follow-up on Subjects, Integrative Data Analysis and Measurement of Viral Antibodies in The Environmental Determinants of Diabetes in The Young Study (TEDDY)
青年糖尿病环境决定因素研究(TEDDY)中的受试者跟踪、综合数据分析和病毒抗体测量
- 批准号:
10260891 - 财政年份:2020
- 资助金额:
$ 62.37万 - 项目类别:
NIDDK Follow-up on Subjects and Immunological Assessments in The Environmental Determinants of Diabetes In The Young Study (TEDDY) (UC4)
NIDDK 青年糖尿病环境决定因素研究 (TEDDY) (UC4) 中受试者和免疫学评估的后续行动
- 批准号:
10088137 - 财政年份:2017
- 资助金额:
$ 62.37万 - 项目类别:
Data Coordinating Center for Type 1 Diabetes TrialNet (UC4)USF: TrialNet UC4-3
1 型糖尿病数据协调中心 TrialNet (UC4)USF:TrialNet UC4-3
- 批准号:
9506924 - 财政年份:2017
- 资助金额:
$ 62.37万 - 项目类别:
Multicenter Interventional Lymphangioleiomyomatosis Early Disease Trial (MILED) - DCC
多中心介入性淋巴管平滑肌瘤病早期疾病试验 (MILED) - DCC
- 批准号:
10249943 - 财政年份:2016
- 资助金额:
$ 62.37万 - 项目类别: